Brand-name drug
Myfortic price, strengths & recalls
Brand of mycophenolic acid (generic)
Pharmacies pay $448.03 for 30 tablets of Myfortic 360 mg delayed-release tablet this week, and from $222.99 to $448.03 across its 2 priced strengths and forms. The generic, mycophenolic acid, costs pharmacies from $3.07. It has 3 recalls on record, none ongoing. Its official label last changed on August 11, 2026.
Brand- Fair cash price
- $525.73
- Strengths
- 2
- Makers
- 1
- Updated
- Nov 11
Myfortic price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 180 mg delayed-release tablet Brand | $7.43 | $222.99 / 30 tablets |
| 360 mg delayed-release tablet Brand | $14.93 | $448.03 / 30 tablets |
Myfortic vs generic mycophenolic acid
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 180 mg delayed-release tablet | $222.99 | $3.07 | 72.7x |
| 360 mg delayed-release tablet | $448.03 | $6.49 | 69x |
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Myfortic
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC.MYFORTIC® (mycophenolic acid) delayed-release tablets, for oral useInitial U.S. Approval: 2004
WARNING: EMBRYO-FETAL TOXICITY, MALIGNANCIES, AND SERIOUS INFECTIONS
Use during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning [see Warnings and Precautions (5.1), Use in Specific Populations (8.1, 8.3)].
Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe Myfortic. Patients receiving Myfortic should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient [see Warnings and Precautions (5.2)].
Increased risk of development of lymphoma and other malignancies, particularly of the skin, due to immunosuppression [see Warnings and Precautions (5.3)].
Increased susceptibility to bacterial, viral, fungal, and protozoal infections, including opportunistic infections [see Warnings and Precautions (5.4, 5.5)].
WARNING: EMBRYO-FETAL TOXICITY, MALIGNANCIES, and SERIOUS INFECTIONS
See full prescribing information for complete boxed warning
Use during pregnancy is associated with increased risks of pregnancy loss and congenital malformations. Avoid if safer treatment options are available. Females of reproductive potential must be counseled regarding pregnancy prevention and planning. (5.1, 8.1, 8.3)
Only physicians experienced in immunosuppressive therapy and management of organ transplant patients should prescribe Myfortic. (5.2)
Increased risk of development of lymphoma and other malignancies, particularly of the skin, due to immunosuppression. (5.3)
Increased susceptibility to bacterial, viral, fungal, and protozoal infections, including opportunistic infections. (5.4, 5.5)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA050791 · Novartis
- First approved
- February 27, 2004 (22 years ago)
- Latest approved change
- July 29, 2026
- Approved label
- PDF, Aug 4, 2026
- Generic makers
- 9 approved generic applications on the market
Myfortic questions
How much does myfortic cost without insurance?
Pharmacies pay about $448.03 for 30 tablets of myfortic 360 mg delayed-release tablet ($14.93 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $525.73. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Myfortic?
Yes: mycophenolic acid. Pharmacies pay from $3.07 for it. Compare mycophenolic acid prices.
Is myfortic in shortage?
No shortage is reported for myfortic right now. We check the national shortage list every day.
Has myfortic been recalled?
3 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the myfortic label last change?
The official label was last updated on August 11, 2026 (version 36). See what changed.
Talk about myfortic
No comments yet. Questions, tips, what worked for you - start the conversation.